Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells

Abstract Background Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. Methods IL-12 levels were measur...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bingyu Shi, Jingjing Qi, Genhong Yao, Ruihai Feng, Zhuoya Zhang, Dandan Wang, Chen Chen, Xiaojun Tang, Liwei Lu, Wanjun Chen, Lingyun Sun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2018-11-01
Sarja:Stem Cell Research & Therapy
Aiheet:
Mesenchymal stem cells
Sjögren’s syndrome
Interleukin-12
Linkit:http://link.springer.com/article/10.1186/s13287-018-1023-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia